|
Amplyx Pharmaceuticals, Inc
@
AmplyxPharma
San Diego, CA
|
|
Developing antifungal agents for the treatment of life-threatening invasive fungal infections due to Candida, Aspergillus and rare molds.
|
|
|
30
Tweetovi
|
66
Pratim
|
54
Osobe koje vas prate
|
| Tweetovi |
| Amplyx Pharmaceuticals, Inc proslijedio/la je tweet | ||
|
Antimicrobials Working Group
@AWG_News
|
31. sij |
|
The #AMR Benchmark Report shows that, despite some progress, R&D has not increased enough to radically impact the problem of AMR. New legislation and regulations are needed to address the broken #antimicrobial market and spur new life saving development reut.rs/2vacFJU
|
||
|
|
||
| Amplyx Pharmaceuticals, Inc proslijedio/la je tweet | ||
|
Antimicrobials Working Group
@AWG_News
|
29. sij |
|
Immediate action is needed to help the companies working to fight #AMR. Learn how legislation like the #DISARMAct can help stabilize the antimicrobial market and spur the development of life-saving treatments: bit.ly/2NVsLh0
|
||
|
|
||
| Amplyx Pharmaceuticals, Inc proslijedio/la je tweet | ||
|
Antimicrobials Working Group
@AWG_News
|
23. sij |
|
#AntimicrobialResistance is evolving faster than new #antimicrobial development. It is critical that policy makers fix the broken market. Learn more about the rising threat of #AMR and how legislation like the #DISARMAct that has potential to help bit.ly/2unzQQO
|
||
|
|
||
|
Amplyx Pharmaceuticals, Inc
@AmplyxPharma
|
22. sij |
|
Hope on the Horizon: Novel Fungal Treatments in Development aspergillus.org.uk/articles/hope-… via @Aspergillus
|
||
|
|
||
|
Amplyx Pharmaceuticals, Inc
@AmplyxPharma
|
22. sij |
|
|
||
| Amplyx Pharmaceuticals, Inc proslijedio/la je tweet | ||
|
CHARM UC San Diego
@CHARM_UCSD
|
18. sij |
|
“We still have a window of opportunity but we need to ensure there is investment now so we don’t run out of options for future generations.” nytimes.com/2020/01/17/hea…
|
||
|
|
||
| Amplyx Pharmaceuticals, Inc proslijedio/la je tweet | ||
|
Helen Boucher
@hboucher3
|
16. sij |
|
Very important session starting - join the discussion on line #AMR @TuftsCIMAR @IDSAInfo @Wellcome_AMR @CARB_X twitter.com/AWG_News/statu…
|
||
|
|
||
| Amplyx Pharmaceuticals, Inc proslijedio/la je tweet | ||
|
Antimicrobials Working Group
@AWG_News
|
17. sij |
|
Without new action, the threat of #AMR will only grow. @PewTrusts shares 5 priorities to combat AMR in 2020, including the use of economic incentives and passing the #DISARMAct to catalyze the development of new life-saving #antimicrobials: bit.ly/2T3e4vK
|
||
|
|
||
| Amplyx Pharmaceuticals, Inc proslijedio/la je tweet | ||
|
Antimicrobials Working Group
@AWG_News
|
5. pro |
|
Lord Jim O'Neill calls for death certificates to include '#superbugs' as cause of death in an effort to raise awareness of the #AntimicrobialResistance crisis and improve the data scientists have to work with. bit.ly/2QXqT9P via @Telegraph #AMR
|
||
|
|
||
| Amplyx Pharmaceuticals, Inc proslijedio/la je tweet | ||
|
Antimicrobials Working Group
@AWG_News
|
2. pro |
|
Almost 3 million #antibiotic resistant infections occur each year in the U.S. @Forbes' @Nic_Fisher details the immense threat #AMR poses & ongoing efforts such as the DISARM Act to fix the broken #antimicrobial market & spur antimicrobial development: bit.ly/2Lfj6Rp
|
||
|
|
||
|
Amplyx Pharmaceuticals, Inc
@AmplyxPharma
|
21. stu |
|
Why the CDC warns antibiotic-resistant fungal infections are an urgent health threat theconversation.com/why-the-cdc-wa… via @ConversationUS
|
||
|
|
||
|
Amplyx Pharmaceuticals, Inc
@AmplyxPharma
|
18. stu |
|
Dr. Karen Shaw will present "Fighting Infections with Fosmanogepix: A first-in-class Antifungal Agent" at the CHARM UC San Diego meeting tomorrow from 4-7pm. Hope to see you there! twitter.com/CHARM_UCSD/sta…
|
||
|
|
||
| Amplyx Pharmaceuticals, Inc proslijedio/la je tweet | ||
|
IDSA
@IDSAInfo
|
18. stu |
|
IDSA’s Faces of Antimicrobial Resistance report highlights patients & their families who have suffered the debilitating effects of #antibioticresistant infections. These heart-wrenching stories demonstrate the urgent need to combat #AMR. bit.ly/2Qsj8sf #USAAW2019 pic.twitter.com/4KkVNGGUld
|
||
|
|
||
|
Amplyx Pharmaceuticals, Inc
@AmplyxPharma
|
13. stu |
|
Drug-Resistant Candida auris is now recognized as an URGENT Threat by the CDC, with an increasing number of strains resistant to all available therapies. New classes of antifungal therapies are needed! #CDCARThreats #AntibioticResistance pic.twitter.com/SWz1ovlowg
|
||
|
|
||
| Amplyx Pharmaceuticals, Inc proslijedio/la je tweet | ||
|
Antimicrobials Working Group
@AWG_News
|
1. stu |
|
In order to spur action necessary to support #antimicrobial innovation, we must continue to effectively communicate how drug-resistance undermines #healthcare and can affect everyone. Learn how from @wellcometrust: bit.ly/2MYHLuw #StopSuperbugs pic.twitter.com/Crwyr8XVso
|
||
|
|
||
| Amplyx Pharmaceuticals, Inc proslijedio/la je tweet | ||
|
Antimicrobials Working Group
@AWG_News
|
1. stu |
|
.@IAmBiotech President & CEO @JimGreenwood highlights the urgent need for new policies like the #DISARMAct that will spur the development of novel #antimicrobials to fight #AMR in his @MorningConsult Op-Ed. bit.ly/2WrUB7Q pic.twitter.com/LWXh6nOSRF
|
||
|
|
||
|
Amplyx Pharmaceuticals, Inc
@AmplyxPharma
|
31. lis |
|
A future without new antimicrobial therapies to address infections caused by resistant pathogens is truly SCARY! At Amplyx, we are proud to be developing innovative therapies for patients at risk for these often life-threatening infections. amplyx.com
|
||
|
|
||
| Amplyx Pharmaceuticals, Inc proslijedio/la je tweet | ||
|
Erin McCreary
@ErinMcCreary
|
26. lis |
|
.@JGPharmD: "antifungal resistance is rising and if you aren't testing, you don't know." #accpam19 pic.twitter.com/Bed8VY0pyp
|
||
|
|
||
| Amplyx Pharmaceuticals, Inc proslijedio/la je tweet | ||
|
Erin McCreary
@ErinMcCreary
|
26. lis |
|
.@jgpharmd: "antifungal resistance is likely underappreciated since many institution do not routinely test Candida species susceptibilities" #accpam19
C. auris concerning due to multi-drug resistance + it is extremely hard to eradicate. pic.twitter.com/zZxZrkGo2Y
|
||
|
|
||
|
Amplyx Pharmaceuticals, Inc
@AmplyxPharma
|
17. lis |
|
We are proud to be a part of the 3X5 family!
Sustainability, Life Sciences Investor 3x5 Doubles Team Amid Fundraising
3x5partners.com/3x5-partners-w…
|
||
|
|
||